Tumor-infiltrating Bregs with a CD19+CD38+CD1d+IgM+CD147+ phenotype have been identified and express key regulatory molecules including IL-10, CD25, and IDO, contributing to suppression of antitumor immune responses (122). This evidence concerns the gene CD19 and neoplasm.